Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab QoL Study in RA
NCT00234936Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2003
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Dec 2003; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00234936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234936.